E-LIB Suche - Ergebnisse für: Staszewski, S

1

Efficacy, adherence and tolerability of once daily tenofovi..:

Esser, S ; Haberl, A ; Mulcahy, F...
European Journal of Medical Research. 16 (2011) 10 - p. 427 , 2011

Link: https://doi.org/10.1186/..

2

Intensification of a failing regimen with zidovudine may ca..:

Stephan, C. ; Dauer, B. ; Bickel, M....
Journal of Infection. 61 (2010) 4 - p. 346-350 , 2010

Link: https://doi.org/10.1016/..

3

The influence of HAART on the efficacy and safety of pegyla..:

Vogel, M ; Ahlenstiel, G ; Hintsche, B...
European Journal of Medical Research. 15 (2010) 3 - p. , 2010

Link: https://doi.org/10.1186/..

4

Human immunodeficiency virus type-1 group M quasispecies ev..:

Biru, T. ; Lennemann, T. ; Stürmer, M....
Medical Microbiology and Immunology. 199 (2010) 4 - p. 323-332 , 2010

Link: https://doi.org/10.1007/..

5

Mutations in the C-terminal region of the HIV-1 reverse tra..:

Michels, I ; Staszewski, S ; Gürtler, L...
European Journal of Medical Research. 15 (2010) 10 - p. 415 , 2010

Link: https://doi.org/10.1186/..

6

Lipometabolic side-effects of three ritonavir-boosted doubl..:

Wendig, A ; Stephan, C ; Khaykin, P...
Journal of the International AIDS Society. 11 (2008) Suppl 1 - p. P122 , 2008

Link: https://doi.org/10.1186/..

7

Virological and immunological response to three boosted pro..:

Baumgardt, C ; Stephan, C ; Haberl, AE...
Journal of the International AIDS Society. 11 (2008) Suppl 1 - p. P32 , 2008

Link: https://doi.org/10.1186/..

8

Both long-term HIV infection and highly active antiretrovir..:

Lorenz, M.W. ; Stephan, C. ; Harmjanz, A....
Atherosclerosis. 196 (2008) 2 - p. 720-726 , 2008

Link: https://doi.org/10.1016/..

9

Infektionen durch intravasale Katheter:

Staszewski, S. ; Dimas, K. ; Stille, W.
DMW - Deutsche Medizinische Wochenschrift. 110 (2008) 2 - p. 43-47 , 2008

Link: https://doi.org/10.1055/..

10

3OD – Once-daily (OD) TDF-containing HAART in HIV-1-infecte..:

Esser, S ; Staszewski, S ; Haberl, AE...
Journal of the International AIDS Society. 11 (2008) Suppl 1 - p. P76 , 2008

Link: https://doi.org/10.1186/..

11

The steady-state pharmacokinetics of atazanavir/ritonavir i..:

von Hentig, N. ; Babacan, E. ; Lennemann, T....
Journal of Antimicrobial Chemotherapy. 62 (2008) 3 - p. 579-582 , 2008

Link: https://doi.org/10.1093/..

12

Factors associated with viral rebound among highly treatmen..:

Smith, CJ ; Phillips, AN ; Dauer, B...
HIV Medicine. 10 (2008) 1 - p. 19-27 , 2008

Link: https://doi.org/10.1111/..

13

[636] THE INFLUENCE OF NUCLEOSIDE FREE HAART ON THE TREATME..:

Rockstroh, J.K. ; Ahlenstiehl, G. ; Vogel, M....
Journal of Hepatology. 46 (2007) - p. S240 , 2007

Link: https://doi.org/10.1016/..

14

Predictors of Virological Outcome and Safety in Primary HIV..:

Hoen, B. ; Cooper, D. A. ; Lampe, F. C....
Clinical Infectious Diseases. 45 (2007) 3 - p. 381-390 , 2007

Link: https://doi.org/10.1086/..

15

Drug Resistance to Tipranavir (TPV) or Darunavir (DRV) Acco..:

STUERMER, M ; DAUER, B ; HABERL, A...
Antiviral Research. 74 (2007) 3 - p. A29-A29 , 2007

Link: https://doi.org/10.1016/..